Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

  • Posted on June 9, 2026
  • By Forbes
  • 0 Views
  • 1 min read
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and obesity treatment, a new report shows.
continue reading...

Author
Forbes

You May Also Like